We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+18.7%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$272M
AUM Growth
–
Cap. Flow
+$259M
Cap. Flow %
95.26%
Top 10 Hldgs %
43.3%
Holding
71
New
71
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$9.27M
2
EW icon
Edwards Lifesciences
EW
+$9.04M
3
BSX icon
Boston Scientific
BSX
+$7.67M
4
RMD icon
ResMed
RMD
+$7.46M
5
ALIM
Alimera Sciences
ALIM
+$5.16M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 32.64%
2 Financials 0.78%
3 Utilities 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
26
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$3.49M 1.28%
+56,100
New +$3.2M
BHC icon
27
Bausch Health
BHC
$2.37B
$3.42M 1.26%
+23,875
New +$3.21M
LLY icon
28
PUT
Eli Lilly
LLY
$1.1T
$3.21M 1.18%
+46,500
New +$3.14M
MCK icon
29
McKesson
MCK
$103B
$3.11M 1.15%
+15,000
New +$3.05M
WMGI
30
DELISTED
Wright Medical Group Inc
WMGI
$3.09M 1.14%
+115,000
New +$3.37M
NUVA
31
DELISTED
NuVasive, Inc.
NUVA
$2.92M 1.07%
+61,850
New +$2.58M
RMD icon
32
CALL
ResMed
RMD
$31.9B
$2.8M 1.03%
+50,000
New +$2.61M
RCPT
33
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$2.76M 1.01%
+22,500
New +$2.28M
MR
34
PUT
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$2.64M 0.97%
+100,000
New +$2.93M
STJ
35
PUT
DELISTED
St Jude Medical
STJ
$2.6M 0.96%
+40,000
New +$2.58M
KITE
36
DELISTED
Kite Pharma, Inc.
KITE
$2.55M 0.94%
+44,250
New +$1.86M
SIEN
37
DELISTED
Sientra, Inc.
SIEN
$2.54M 0.93%
+15,112
New +$2.58M
TRNX
38
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$2.52M 0.93%
+99,000
New +$2.52M
CELG
39
PUT
DELISTED
Celgene Corp
CELG
$2.52M 0.93%
+22,500
New +$2.37M
VNDA icon
40
CALL
Vanda Pharmaceuticals
VNDA
$304M
$2.51M 0.92%
+175,000
New +$2.07M
HRC
41
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.28M 0.84%
+50,000
New +$2.22M
NVRO
42
DELISTED
NEVRO CORP.
NVRO
$2.2M 0.81%
+56,900
New +$1.79M
EVAR
43
DELISTED
Lombard Medical, Inc.
EVAR
$2.18M 0.8%
+336,025
New +$2.2M
NXTM
44
DELISTED
NxStage Medical Inc.
NXTM
$2.15M 0.79%
+120,000
New +$1.93M
NVCN
45
DELISTED
Neovasc Inc.
NVCN
$2.13M 0.78%
+13
New +$1.96M
GILD icon
46
Gilead Sciences
GILD
$165B
$2.12M 0.78%
+22,500
New +$2.33M
EHTH icon
47
eHealth
EHTH
$40.4M
$2.12M 0.78%
+85,000
New +$2.07M
RAD
48
CALL
DELISTED
Rite Aid Corporation
RAD
$2.07M 0.76%
+13,750
New +$1.53M
MDVN
49
PUT
DELISTED
MEDIVATION, INC.
MDVN
$1.89M 0.7%
+38,000
New +$1.98M
TEVA icon
50
Teva Pharmaceuticals
TEVA
$42.1B
$1.81M 0.67%
+31,500
New +$1.75M
1
2
3

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return

Pura Vida Investments's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Pura Vida Investments, which disclosed 71 positions worth $272M. Its ten largest holdings account for 43% of the portfolio.

Its largest position is Intuitive Surgical: 166,500 shares worth $9.79M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, followed by Financials and Utilities.

  • Pura Vida Investments's largest Q4 2014 buy was Intuitive Surgical: 166,500 shares worth $9.79M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $272M portfolio in Q4 2014.
  • Pura Vida Investments disclosed 71 positions in Q4 2014, its first 13F filing on record.

Based on Pura Vida Investments's 13F filing for Q4 2014, filed 17 Feb 2015.